We are live on ! Find out more
LABU icon

Direxion Daily S&P Biotech Bull 3X ETF
LABU

41 hedge funds and large institutions have $84.4M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

348% more capital invested

Capital invested by funds: $18.8M → $84.4M (+$65.6M)

163% more call options, than puts

Call options by funds: $246M | Put options by funds: $93.4M

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

6.56% more ownership

Funds ownership: 0.11% → 6.67% (+6.6%)

13% less funds holding

Funds holding: 47 → 41 (-6)

18% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 22

Holders
41
Holders Change
-6
Holders Change %
-12.77%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
11
Reduced
7
Closed
22
Calls
$246M
Puts
$93.4M
Net Calls
+$153M
Net Calls Change
+$156M

Top Buyers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
+$11.6M
2
Morgan Stanley
Morgan Stanley
New York
+$8.5M
3
Jane Street
Jane Street
New York
+$6.16M
4
Squarepoint
Squarepoint
New York
+$3.14M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.27M

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$1.94M
2
Simplex Trading
Simplex Trading
Illinois
-$856K
3
IMC Chicago
IMC Chicago
Illinois
-$854K
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$524K
5
Corient Private Wealth
Corient Private Wealth
Florida
-$356K
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
26
SG Americas Securities
New York
$186K -$11.9K -155 -9%
Citigroup
27
Citigroup
New York
$173K -$11.6K -151 -10%
Simplex Trading
28
Simplex Trading
Illinois
$155K -$856K -11,189 -90%
Bank of America
29
Bank of America
North Carolina
$90K -$28.2K -368 -33%
Qube Research & Technologies (QRT)
30
Qube Research & Technologies (QRT)
United Kingdom
$52.9K +$28.9K +378 +675%
PS
31
PayPay Securities
Japan
$33K -$18.4K -240 -47%
HI
32
Hoey Investments
Pennsylvania
$23.2K – – –
S
33
SignatureFD
Georgia
$21.3K +$13.4K +175 New
ASN
34
Advisory Services Network
Georgia
$21.1K +$13.2K +173 New
TFA
35
Toth Financial Advisory
Virginia
$9.76K +$6.12K +80 New
CPG
36
Cornerstone Planning Group
New Jersey
$4.27K – – –
TFM
37
TFC Financial Management
Massachusetts
$3.05K – – –
LA
38
LM Advisors
California
$2.07K +$1.3K +17 New
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$2K +$1.53K +20 New
US Bancorp
40
US Bancorp
Minnesota
$1.83K – – –
Wells Fargo
41
Wells Fargo
California
$1.22K +$765 +10 New
HF
42
HRT Financial
New York
– -$1.94M -25,490 Closed
IMC Chicago
43
IMC Chicago
Illinois
– -$854K -11,206 Closed
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
– -$524K -6,875 Closed
Corient Private Wealth
45
Corient Private Wealth
Florida
– -$356K -4,675 Closed
NA
46
NewEdge Advisors
Louisiana
– -$39.8K -3,225 Closed
LC
47
Lindbrook Capital
California
– -$237K -3,110 Closed
FAM
48
Formidable Asset Management
Ohio
– -$153K -2,012 Closed
KA
49
Kovack Advisors
Florida
– -$114K -1,500 Closed
ICG
50
InterOcean Capital Group
Tennessee
– -$83.8K -1,100 Closed
1
2
3

LABU Hedge Fund Activity: Q4 2023 in Review

41 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2023, worth a combined $84.4M — up 348% from $18.8M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of LABU and 18 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 11 added.

The largest buyer was Barclays, opening a new position worth an estimated $11.6M. The largest seller was HRT Financial, exiting entirely with an estimated $1.94M sold.

  • 41 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2023, down from 47 in Q3 2023.
  • Funds reported $84.4M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2023, up 348% quarter-over-quarter.
  • 18 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2023 and 22 closed out, a net change of -4 holders.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2023 was Barclays, an estimated $11.6M added.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2023 was HRT Financial, an estimated $1.94M sold.

Based on aggregated 13F filings for Q4 2023.